Published by Iain Gilbert on 23rd October 2018
(Sharecast News) - US biotech Biogen saw third-quarter profits come in ahead of analysts' estimates as a result of double-digit sales growth of its muscular atrophy treatment Spinraza.
URL: http://www.digitallook.com/dl/news/story/28173342/...